Cargando…
Practice guidelines and clinical risk assessment models: is it time to reform?
BACKGROUND: Clinical practice guidelines and Risk Assessment Models (RAMs) are some useful tools to bring medical evidences into our daily clinical practice. Despite the improvement over the time, they still have some shortcomings. DISCUSSION: One of these shortcomings is the arbitrary cutoffs used...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3210091/ https://www.ncbi.nlm.nih.gov/pubmed/22008213 http://dx.doi.org/10.1186/1472-6947-11-63 |
_version_ | 1782215703144693760 |
---|---|
author | Sepehrvand, Nariman Pakdel, Firouz Ghaderi Rahimi-Rad, Mohammad Hosein Moosavi-Toomatari, Babak Bazargan-Hejazi, Shahrzad |
author_facet | Sepehrvand, Nariman Pakdel, Firouz Ghaderi Rahimi-Rad, Mohammad Hosein Moosavi-Toomatari, Babak Bazargan-Hejazi, Shahrzad |
author_sort | Sepehrvand, Nariman |
collection | PubMed |
description | BACKGROUND: Clinical practice guidelines and Risk Assessment Models (RAMs) are some useful tools to bring medical evidences into our daily clinical practice. Despite the improvement over the time, they still have some shortcomings. DISCUSSION: One of these shortcomings is the arbitrary cutoffs used in these tools to facilitate the decision making process. This problem is to some extent due to the "Black or White" approach of modern medicine in making the decisions, whilst in the real world and our daily practice we used mostly an uncertain approach, which is called recently as "Fuzzy" thinking approach. SUMMARY: The authors of this article believe that the fuzzy type of thinking may resolve the above mentioned shortcomings of clinical practice guideline or risk assessment models and they tried to discuss about this using an example about Venous Thromboembolism related guidelines and RAMs. |
format | Online Article Text |
id | pubmed-3210091 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-32100912011-11-08 Practice guidelines and clinical risk assessment models: is it time to reform? Sepehrvand, Nariman Pakdel, Firouz Ghaderi Rahimi-Rad, Mohammad Hosein Moosavi-Toomatari, Babak Bazargan-Hejazi, Shahrzad BMC Med Inform Decis Mak Debate BACKGROUND: Clinical practice guidelines and Risk Assessment Models (RAMs) are some useful tools to bring medical evidences into our daily clinical practice. Despite the improvement over the time, they still have some shortcomings. DISCUSSION: One of these shortcomings is the arbitrary cutoffs used in these tools to facilitate the decision making process. This problem is to some extent due to the "Black or White" approach of modern medicine in making the decisions, whilst in the real world and our daily practice we used mostly an uncertain approach, which is called recently as "Fuzzy" thinking approach. SUMMARY: The authors of this article believe that the fuzzy type of thinking may resolve the above mentioned shortcomings of clinical practice guideline or risk assessment models and they tried to discuss about this using an example about Venous Thromboembolism related guidelines and RAMs. BioMed Central 2011-10-18 /pmc/articles/PMC3210091/ /pubmed/22008213 http://dx.doi.org/10.1186/1472-6947-11-63 Text en Copyright ©2011 Sepehrvand et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Debate Sepehrvand, Nariman Pakdel, Firouz Ghaderi Rahimi-Rad, Mohammad Hosein Moosavi-Toomatari, Babak Bazargan-Hejazi, Shahrzad Practice guidelines and clinical risk assessment models: is it time to reform? |
title | Practice guidelines and clinical risk assessment models: is it time to reform? |
title_full | Practice guidelines and clinical risk assessment models: is it time to reform? |
title_fullStr | Practice guidelines and clinical risk assessment models: is it time to reform? |
title_full_unstemmed | Practice guidelines and clinical risk assessment models: is it time to reform? |
title_short | Practice guidelines and clinical risk assessment models: is it time to reform? |
title_sort | practice guidelines and clinical risk assessment models: is it time to reform? |
topic | Debate |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3210091/ https://www.ncbi.nlm.nih.gov/pubmed/22008213 http://dx.doi.org/10.1186/1472-6947-11-63 |
work_keys_str_mv | AT sepehrvandnariman practiceguidelinesandclinicalriskassessmentmodelsisittimetoreform AT pakdelfirouzghaderi practiceguidelinesandclinicalriskassessmentmodelsisittimetoreform AT rahimiradmohammadhosein practiceguidelinesandclinicalriskassessmentmodelsisittimetoreform AT moosavitoomataribabak practiceguidelinesandclinicalriskassessmentmodelsisittimetoreform AT bazarganhejazishahrzad practiceguidelinesandclinicalriskassessmentmodelsisittimetoreform |